Related Experiment Video

Updated: Aug 17, 2026

Rapid Scan Electron Paramagnetic Resonance Opens New Avenues for Imaging Physiologically Important Parameters In Vivo
08:01

Rapid Scan Electron Paramagnetic Resonance Opens New Avenues for Imaging Physiologically Important Parameters In Vivo

Published on: September 26, 2016

Evaluation of adriamycin nephropathy by an in vivo electron paramagnetic resonance

Takaaki Oteki1, Sohji Nagase, Hidekatsu Yokoyama

  • 1Pathophysiology of Renal Diseases, Medical Sciences for Control of Pathological Processes, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan.

Biochemical and Biophysical Research Communications
|May 25, 2005
PubMed

Insights

Adriamycin-induced nephropathy in rats shows reduced kidney reducing ability before protein in urine appears. This impairment, measured by electron paramagnetic resonance (EPR), is linked to mitochondrial dysfunction.

Area of Science:

  • Nephrology
  • Biochemistry
  • Medical Physics

Background:

  • Minimal change nephropathy is a significant cause of nephrotic syndrome.
  • Adriamycin (ADR) is a common chemotherapeutic agent that can induce nephropathy.
  • Assessing renal reducing ability is crucial for understanding kidney disease progression.

Purpose of the Study:

  • To investigate the temporal changes in renal reducing ability in a rat model of adriamycin-induced nephropathy.
  • To correlate changes in renal reducing ability with the onset of proteinuria.
  • To explore the mitochondrial contribution to impaired renal reducing ability.

Main Methods:

  • Established a rat model of minimal change nephropathy using intravenous adriamycin (5 mg/kg).
  • Utilized in vivo electron paramagnetic resonance (EPR) spectroscopy at 700 MHz to measure nitroxide radical (TEMPOL) signal decay.
  • Conducted in vitro EPR studies to assess mitochondrial reducing capacity.

Main Results:

  • Renal reducing ability, indicated by TEMPOL signal decay rate, declined by day 7 post-ADR administration.
  • Renal reducing ability began to recover after day 14.
  • Impairment of renal reducing ability preceded the development of continuous proteinuria.
  • In vitro studies linked the observed in vivo impairment to mitochondrial dysfunction.

Conclusions:

  • Adriamycin-induced nephropathy is characterized by an early decline in renal reducing ability.
  • Impaired mitochondrial function contributes to the reduction in renal reducing ability.
  • EPR spectroscopy is a valuable tool for monitoring early functional changes in nephropathy.

More Related Videos

In Vivo EPR Assessment of pH, pO2, Redox Status, and Concentrations of Phosphate and Glutathione in the Tumor Microenvironment10:46

In Vivo EPR Assessment of pH, pO2, Redox Status, and Concentrations of Phosphate and Glutathione in the Tumor Microenvironment

Published on: March 16, 2018

Use of Electron Paramagnetic Resonance in Biological Samples at Ambient Temperature and 77 K06:45

Use of Electron Paramagnetic Resonance in Biological Samples at Ambient Temperature and 77 K

Published on: January 11, 2019

Related Concept Videos

Effects of EDTA on End-Point Detection Methods01:18

Effects of EDTA on End-Point Detection Methods

Different methods, such as visual observance of metal-ion indicators, spectroscopic techniques, and potentiometric methods, can determine the endpoint of an EDTA titration.
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a result, EDTA...